Previous 10 | Next 10 |
2023-08-21 13:53:35 ET Despite sharp YTD declines, shares of COVID-19 vaccine makers traded higher on Monday as a newly-detected Omicron variant continued to gain ground amid a concurrent rise in COVID-related hospitalizations. Notable gainers include Novavax ( NASDAQ: NVAX ), M...
2023-08-17 09:45:00 ET Novavax (NASDAQ: NVAX) has gone from a pandemic darling to a bust, with its shares falling by a whopping 83% over the past 12 months. The hope and optimism surrounding the stock has faded. Earlier this month, the company reported a surprise profit, briefly cre...
2023-08-14 14:57:17 ET Summary Novavax announced Q2 2023 earnings last week - revenues were $424m, net income was $58m. It's an improved performance for the bottom line after the COVID vaccine maker made net losses of $(668)m and $(1.7bn) in 2022 and 2021. The company is focus...
2023-08-13 12:00:00 ET With the pandemic in the rearview mirror, Wall Street has mixed views on the prospects of COVID-19 vaccine makers, as the group, once the favorite among investors, is grappling with a slump in sales amid falling infections. The FDA-Authorized COVID-19 makers in th...
2023-08-11 08:50:00 ET As conventional investment wisdom has it, it's best to buy low and sell high. However, that only works when you have solid reasons to believe a company's shares will bounce back meaningfully after a decline. Some corporations have uncertain prospects that make the...
2023-08-10 18:48:16 ET There's nothing like a surge in a deadly disease to encourage investors back into a noted healthcare stock. This dynamic benefited biotech Novavax (NASDAQ: NVAX) on Thursday. It was also on the back of one pundit's recommendation upgrade; together these fa...
2023-08-09 13:10:29 ET More on Pfizer, Moderna, etc. Moderna, Inc. ( MRNA ) Q2 2023 Earnings Call Transcript Moderna, Inc. 2023 Q2 - Results - Earnings Call Presentation Pfizer Inc. ( PFE ) Q2 2023 Earnings Call Transcript Cardiff Oncology soars as Pf...
2023-08-08 13:31:04 ET Novavax, Inc. (NVAX) Q2 2023 Earnings Conference Call August 08, 2023 08:30 AM ET Company Participants Erika Schultz - Senior Director, IR John Jacob - President and CEO Filip Dubovsky - CMO John Trizzino - CCO and CBO James Kelly -...
2023-08-08 08:06:44 ET More on Novavax Novavax Faces Uphill Battle In Competitive Vaccine Market: Analysis And Recommendation Novavax: Sell The Covid Rips Novavax, Inc. ( NVAX ) Presents at BofA Securities 2023 Health Care Conference Seeking Alpha’...
Novavax Reports Second Quarter 2023 Financial Results and Operational Highlights PR Newswire Second quarter total revenue of $424 million and net income of $58 million Executed new strategic partnering agreement with SK bioscience, including an equity investm...
News, Short Squeeze, Breakout and More Instantly...
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...